Sickle Cell Disease
Sickle Cell Disease is an inherited blood disorder that predominantly affects Black people. In the US, sickle cell disease occurs in approximately 1 out of every 365 Black or African-American births. Sickle Cell Disease has long been neglected, resulting in limited improvement in mortality in the last four decades. However, exciting new technologies and medicines with great potential are currently being studied to combat the disease. Our new enterprise-wide program aims to provide innovative, compassionate, patient-centered care.
Areas of focus include:
- Standardizing clinical pathways
- Expanding access to virtual care
- Providing seamless transitions from pediatric to adult care
- Enhancing access to advanced therapies
- Supporting multi-center clinical trials
- Increasing awareness about sickle cell disease. Learn more.
